Skip to content

Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients

Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02156583
Enrollment
20
Registered
2014-06-05
Start date
2014-05-31
Completion date
2017-07-31
Last updated
2018-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systolic Heart Failure

Keywords

Ventricular Assist Device, Skeletal Muscle, Frailty, Older adults

Brief summary

This is an observational study evaluating changes in frailty and associated impairments in older heart failure patients receiving left ventricular assist device therapy.

Interventions

None listed

Sponsors

Thoratec Corporation
CollaboratorINDUSTRY
National Skeletal Muscle Research Center
CollaboratorUNKNOWN
Greater New York Geriatric Cardiology Consortium
CollaboratorUNKNOWN
Thomas Jefferson University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 years old or older * Scheduled to undergo left ventricular assist device implantation at Thomas Jefferson University

Exclusion criteria

* Unable or unwilling to provide informed consent * Unable to complete baseline frailty assessment

Design outcomes

Primary

MeasureTime frameDescription
Change in frailty following left ventricular assist device implantationBaseline (prior to surgery); 10 days, 1 month, 3 months, and 6 months post-operativelyFrailty will be assess based on the domains initially described by Fried and colleagues: weakness, low physical activity, unintentional weight loss, slowness and exhaustion. Additional frailty measures include the Short Physical Performance Battery (SPPB), as well as gait speed and hand grip strength as single item measures.

Secondary

MeasureTime frame
Skeletal muscle size as measured by ultrasonographyBaseline (prior to surgery); 10 days and 3 months postoperatively

Other

MeasureTime frame
Cognitive function measured by the Montreal Cognitive AssessmentBaseline; 3 and 6 months post-operatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026